Vu Thuy Duong1,2, Le Thi Phuong Tu1, Ha Thanh Tuyen1, Le Thi Quynh Nhi1,3, James I Campbell1, Pham Van Minh1, Hoang Le Phuc2, Tran Thi Hong Chau1, Nguyen Minh Ngoc4, Lu Lan Vi5, Claire Jenkins6, Iruka Okeke7, Ellen Higginson8, Stephen Baker9. 1. The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. 2. Children's Hospital 1, Ho Chi Minh City, Vietnam. 3. University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. 4. Children's Hospital 2, Ho Chi Minh City, Vietnam. 5. The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. 6. National Infection Service, Public Health England, England, UK. 7. Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria. 8. Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) Department of Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK. 9. Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) Department of Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK. sgb47@medschl.cam.ac.uk.
Correction: BMC Microbiol 20, 192 (2020)10.1186/s12866-020-01878-5Following publication of the original article [1], the authors subsequently identified an error in one of the probe sequences. The probe used for the detection of rfbO157 gene in the EHEC multiplex PCR was incorrect. The correct sequence of the probe should be LCCyan500-TAGGACCGCAGAGGAAAGAGAGGAAT-BHQ1”.
Authors: Vu Thuy Duong; Le Thi Phuong Tu; Ha Thanh Tuyen; Le Thi Quynh Nhi; James I Campbell; Pham Van Minh; Hoang Le Phuc; Tran Thi Hong Chau; Nguyen Minh Ngoc; Lu Lan Vi; Claire Jenkins; Iruka Okeke; Ellen Higginson; Stephen Baker Journal: BMC Microbiol Date: 2020-07-03 Impact factor: 4.465